Amgen (AMGN) Consolidated Net Income (2016 - 2025)
Historic Consolidated Net Income for Amgen (AMGN) over the last 17 years, with Q4 2025 value amounting to $1.3 billion.
- Amgen's Consolidated Net Income rose 11259.97% to $1.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.7 billion, marking a year-over-year increase of 8853.3%. This contributed to the annual value of $7.7 billion for FY2025, which is 8853.3% up from last year.
- Amgen's Consolidated Net Income amounted to $1.3 billion in Q4 2025, which was up 11259.97% from $3.2 billion recorded in Q3 2025.
- In the past 5 years, Amgen's Consolidated Net Income registered a high of $3.2 billion during Q3 2025, and its lowest value of -$113.0 million during Q1 2024.
- In the last 5 years, Amgen's Consolidated Net Income had a median value of $1.5 billion in 2022 and averaged $1.5 billion.
- Per our database at Business Quant, Amgen's Consolidated Net Income crashed by 10397.75% in 2024 and then skyrocketed by 163097.35% in 2025.
- Amgen's Consolidated Net Income (Quarter) stood at $1.9 billion in 2021, then fell by 14.9% to $1.6 billion in 2022, then tumbled by 52.54% to $767.0 million in 2023, then dropped by 18.25% to $627.0 million in 2024, then skyrocketed by 112.6% to $1.3 billion in 2025.
- Its Consolidated Net Income was $1.3 billion in Q4 2025, compared to $3.2 billion in Q3 2025 and $1.4 billion in Q2 2025.